tert-Butyl 4-(hydroxymethyl)phenylcarbamate, 95.0%, 100g

ETHYL 6-CHLORO-4-(CYCLOPROPYLAMINO)NICOTINATE, 95%, 25g

TASELISIB, 95%, 50mg

2-BROMO-4-FLUORO-6-METHOXYANILINE, 95.0%, 5g

Ethyl 5-(hydroxymethyl)-1-methyl-1H-pyrazole-3-carboxylate, 98%, 250mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 100, 4000 ml, 190 mm, 1 Piece

1-Chloro-3-iodobenzene, 98.0%, 100g

7-bromo-2,3-dihydro-1,3-benzothiazole-2-thione, 95%, 250mg

(1S,2S)-Cyclohexane-1,2-diol, 99+%, 50mg

2-(3-Amino-1H-pyrazol-1-yl)ethanol, 95.0%, 1g

Methyl 4-bromobenzo[b]thiophene-2-carboxylate, 95.0%, 25g

Bis(2-butoxyethyl) Adipate>97.0%(GC)25g

4-[(6-Cyclopropylamino-pyrimidin-4-yl)-methyl-amino]-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg